The Effect of Continuous Subcutaneous Insulin Infusion on Very-Low-Density Lipoprotein Triglyceride Metabolism in Type I Diabetes Mellitus

Diabetes ◽  
1983 ◽  
Vol 32 (1) ◽  
pp. 75-81 ◽  
Author(s):  
A. O. Pietri ◽  
F. L. Dunn ◽  
S. M. Grundy ◽  
P. Raskin
Keyword(s):  
Diabetes Mellitus ◽  
Continuous Subcutaneous Insulin Infusion ◽  
Insulin Infusion ◽  
Type I Diabetes ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Type I ◽  
Very Low Density Lipoprotein ◽  
Low Density ◽  
Subcutaneous Insulin

scholarly journals Analytical Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Children and Adolescents with Type I Diabetes Mellitus

2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Siddig AA ◽  
Bui TDMP ◽  
Readon DR ◽  
Ven M ◽  
Bailes Z ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Continuous Subcutaneous Insulin Infusion ◽  
Insulin Infusion ◽  
Type I Diabetes ◽  
Type I Diabetes Mellitus ◽  
Type I ◽  
Subcutaneous Insulin ◽  
Children And Adolescent ◽  
Multiple Daily Insulin Injections ◽  
Better Than

Introduction: Continuous subcutaneous insulin infusion (CSII) is a form of insulin administration for patients with type I diabetes mellitus (T1DM) that was introduced as a means of stimulating normal plasma insulin fluctuations and provide better metabolic control that is better than multiple daily insulin injections (MDI). The purpose of this study was to determine the effect of CSII as compared to MDI in the treatment of T1DM in children and adolescent below 20 years of age.

Sign in / Sign up

Export Citation Format

Share Document